S. Raymond Golish
S. Raymond Golish has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Todd F. Alamin
Department of Orthopaedic Surgery, Stanford University, 450 Broadway St, Redwood City, CA 94063, USA
2 shared publicationsAgnes Ith
Department of Orthopaedic Surgery, Stanford University, 450 Broadway St, Redwood City, CA 94063, USA
1 shared publication- Eugene J. Carragee
Stanford University Hospital and Clinics
1 shared publication Gaetano J. Scuderi
Department of Orthopaedic Surgery, Stanford University, 450 Broadway St, Redwood City, CA 94063, USA
1 shared publication- Ivan Cheng
Department of Orthopaedic Surgery, Stanford University School of Medicine, 450 Broadway St, MC 6342, Redwood City, CA 94063, USA
1 shared publication Jason A. Oliviero
1 shared publication
Latest Publications
- 1 February 2019
- Published by Elsevier in The Spine Journal
- Vol. 19 (2) , e28-e33
Does the presence of the fibronectin-aggrecan complex predict outcomes from lumbar discectomy for disc herniation?
- 1 February 2019
- Published by Elsevier in The Spine Journal
- Vol. 19 (2) , e28-e33
Does the presence of the fibronectin-aggrecan complex predict outcomes from lumbar discectomy for disc herniation?
- Open Access
- 24 July 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 348
Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
The United States Food and Drug Administration (FDA) reviews class III orthopedic devices submitted for premarket approval with pivotal clinical trials. The purpose of this study was to determine the types of orthopedic devices reviewed, the design of their pivotal clinical trials, and the subjective factors affecting the interpretation of clinical trial data. Meetings of the FDA Orthopaedic and Rehabilitation Devices Panel were identified from 2000–2016. Meeting materials were collected from FDA electronic archives and notes were made regarding the device-type and subsequent approval and recall, the design of pivotal clinical trials, and issues of trial interpretation debated during panel deliberations. The panel was convened on 29 separate occasions over the course of 35 days to deliberate 38 distinct topics. Of these, 23 topics included clinical data submitted for approval of a device, and two topics were excluded. Of the 23 devices, five were biologic, three were hip arthroplasty, three were disc arthroplasty, two were viscosupplementation, three were interspinous process devices, and seven were other devices. Of the 23 pivotal trials, 20 (87.0%) were randomized controlled trials (RCTs), consisting of 13 (65.0%) non-inferiority trials and 7 (35.0%) superiority trials, and all RCTs were two-arm trials. At panel, the most commonly debated issues were related to the design and interpretation of non-inferiority trials. A broad array of device types is reviewed by the FDA. The predominance of two-arm non-inferiority trials as pivotal studies indicates that the nuances of their design and interpretation are commercially important.
- 24 July 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 348
Open AccessPivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
The United States Food and Drug Administration (FDA) reviews class III orthopedic devices submitted for premarket approval with pivotal clinical trials. The purpose of this study was to determine the types of orthopedic devices reviewed, the design of their pivotal clinical trials, and the subjective factors affecting the interpretation of clinical trial data. Meetings of the FDA Orthopaedic and Rehabilitation Devices Panel were identified from 2000–2016. Meeting materials were collected from FDA electronic archives and notes were made regarding the device-type and subsequent approval and recall, the design of pivotal clinical trials, and issues of trial interpretation debated during panel deliberations. The panel was convened on 29 separate occasions over the course of 35 days to deliberate 38 distinct topics. Of these, 23 topics included clinical data submitted for approval of a device, and two topics were excluded. Of the 23 devices, five were biologic, three were hip arthroplasty, three were disc arthroplasty, two were viscosupplementation, three were interspinous process devices, and seven were other devices. Of the 23 pivotal trials, 20 (87.0%) were randomized controlled trials (RCTs), consisting of 13 (65.0%) non-inferiority trials and 7 (35.0%) superiority trials, and all RCTs were two-arm trials. At panel, the most commonly debated issues were related to the design and interpretation of non-inferiority trials. A broad array of device types is reviewed by the FDA. The predominance of two-arm non-inferiority trials as pivotal studies indicates that the nuances of their design and interpretation are commercially important.
- 10 October 2016
- Published by Elsevier in The Spine Journal
- Vol. 17 (1) , 150-157
Spinal devices in the United States—investigational device exemption trials and premarket approval of class III devices
- 10 October 2016
- Published by Elsevier in The Spine Journal
- Vol. 17 (1) , 150-157
Spinal devices in the United States—investigational device exemption trials and premarket approval of class III devices
- 1 August 2012
- Published by Elsevier in The Spine Journal
- Vol. 12 (8) , 693-701
Bearing surfaces for total disc arthroplasty: metal-on-metal versus metal-on-polyethylene and other biomaterials
- 1 August 2012
- Published by Elsevier in The Spine Journal
- Vol. 12 (8) , 693-701
Bearing surfaces for total disc arthroplasty: metal-on-metal versus metal-on-polyethylene and other biomaterials
- 1 July 2012
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 17 (1) , 69-73
Failure strength of lumbar spinous processes loaded in a tension band model
Object: There has been increasing interest in spinous process tension band devices, as distinct from spinous process spacers and plates. The purpose of this study was to load spinous processes caudally at L-4 and cranially at L-5 parallel to the long axis of the spine in a biomechanical model of tension band loading. The goal was to provide normative data for the design of a spinous process tension band device after varying degrees of surgical decompression and across varying bone mineral densities (BMDs). Methods: Fresh-frozen L4–5 lumbar vertebrae pairs were divided into 3 surgical groups: intact, midline-sparing decompression (laminotomy and medial facetectomy), and midline decompression with foraminotomy (one-half of spinous process resected, laminotomy, and medial facetectomy). After decompression, specimens were disarticulated into isolated L-4 and L-5 vertebrae. Each vertebra was loaded to failure in a caudal (L-4) or cranial (L-5) direction parallel to the long axis of the spine via a 6-mm-wide strap looped around the spinous process. Failure strength and mode were recorded. Results: Seventeen L-4 and L-5 lumbar vertebrae were tested from 17 cadavers. There were 10 male (59%) and 7 female (41%) cadavers, with a mean age of 66.6 ± 16.5 years (range 41–100 years) and a mean BMD of 1 ± 0.23 g/cm2 (range 0.66–1.34 g/cm2); the mean is expressed ± SD throughout. For data analysis, specimens were grouped into those with no or midline-sparing decompression (Group 1: 11 of 17) and those with midline decompression (Group 2: 6 of 17). At L-4, the mean failure strength for Group 1 was 453 ± 162 N, and for Group 2 it was 264 ± 99 N (p = 0.02; Cohen's d = 1.4). At L-5, the mean failure strength for Group 1 was 517 ± 190 N, and for Group 2 it was 269 ± 184 N (p = 0.02; Cohen's d = 1.3). There was no significant difference in failure strength between the intact and midline-sparing decompression groups at L-4 (p = 0.91) or L-5 (p = 0.41). Conclusions: Across specimens with a wide range of BMDs, midline-sparing decompression was not found to decrease the mean failure strength of the L-4 and L-5 spinous processes (453 and 517 N, respectively), whereas midline surgical decompression decreased the failure strength of these processes (264 and 269 N, respectively) in a biomechanical model of tension band loading relevant to the design of a tension band device.
- 1 July 2012
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 17 (1) , 69-73
Failure strength of lumbar spinous processes loaded in a tension band model
Object: There has been increasing interest in spinous process tension band devices, as distinct from spinous process spacers and plates. The purpose of this study was to load spinous processes caudally at L-4 and cranially at L-5 parallel to the long axis of the spine in a biomechanical model of tension band loading. The goal was to provide normative data for the design of a spinous process tension band device after varying degrees of surgical decompression and across varying bone mineral densities (BMDs). Methods: Fresh-frozen L4–5 lumbar vertebrae pairs were divided into 3 surgical groups: intact, midline-sparing decompression (laminotomy and medial facetectomy), and midline decompression with foraminotomy (one-half of spinous process resected, laminotomy, and medial facetectomy). After decompression, specimens were disarticulated into isolated L-4 and L-5 vertebrae. Each vertebra was loaded to failure in a caudal (L-4) or cranial (L-5) direction parallel to the long axis of the spine via a 6-mm-wide strap looped around the spinous process. Failure strength and mode were recorded. Results: Seventeen L-4 and L-5 lumbar vertebrae were tested from 17 cadavers. There were 10 male (59%) and 7 female (41%) cadavers, with a mean age of 66.6 ± 16.5 years (range 41–100 years) and a mean BMD of 1 ± 0.23 g/cm2 (range 0.66–1.34 g/cm2); the mean is expressed ± SD throughout. For data analysis, specimens were grouped into those with no or midline-sparing decompression (Group 1: 11 of 17) and those with midline decompression (Group 2: 6 of 17). At L-4, the mean failure strength for Group 1 was 453 ± 162 N, and for Group 2 it was 264 ± 99 N (p = 0.02; Cohen's d = 1.4). At L-5, the mean failure strength for Group 1 was 517 ± 190 N, and for Group 2 it was 269 ± 184 N (p = 0.02; Cohen's d = 1.3). There was no significant difference in failure strength between the intact and midline-sparing decompression groups at L-4 (p = 0.91) or L-5 (p = 0.41). Conclusions: Across specimens with a wide range of BMDs, midline-sparing decompression was not found to decrease the mean failure strength of the L-4 and L-5 spinous processes (453 and 517 N, respectively), whereas midline surgical decompression decreased the failure strength of these processes (264 and 269 N, respectively) in a biomechanical model of tension band loading relevant to the design of a tension band device.
- 1 January 2009
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 22 (02) , 106-110
The Graft/Femoral Tunnel Angles in Posterior Cruciate Ligament Reconstruction –A Comparison of 3 Techniques for Femoral Tunnel Placement
This study compared the graft/femoral tunnel angle produced with the outside-in technique with the inside-out technique at 90° and 120° of flexion. Three femoral tunnels were marked with guide-wires and measured radiographically in 8 fresh-frozen cadaveric knees using both techniques. Results were analyzed. The mean graft/femoral tunnel angle was 34.4°±14.4° for the outside-in technique, 52.3°±14.1° for the inside-out technique at 120° of flexion, and 74.4°±11° for the inside-out technique at 90° of flexion. The angle was smaller for the outside-in technique versus the inside-out technique at both 120° (P = .019) and 90° of knee flexion (P < .001). The outside-in technique for femoral tunnel placement produces the lowest graft/femoral tunnel angle in cadavers. With the inside-out technique, 120° of flexion produces smaller angles than does 90° of flexion. The outside-in technique results in lower angles and perhaps lower graft failure rates. However, additional clinical studies are needed.
- 1 January 2009
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 22 (02) , 106-110
The Graft/Femoral Tunnel Angles in Posterior Cruciate Ligament Reconstruction –A Comparison of 3 Techniques for Femoral Tunnel Placement
This study compared the graft/femoral tunnel angle produced with the outside-in technique with the inside-out technique at 90° and 120° of flexion. Three femoral tunnels were marked with guide-wires and measured radiographically in 8 fresh-frozen cadaveric knees using both techniques. Results were analyzed. The mean graft/femoral tunnel angle was 34.4°±14.4° for the outside-in technique, 52.3°±14.1° for the inside-out technique at 120° of flexion, and 74.4°±11° for the inside-out technique at 90° of flexion. The angle was smaller for the outside-in technique versus the inside-out technique at both 120° (P = .019) and 90° of knee flexion (P < .001). The outside-in technique for femoral tunnel placement produces the lowest graft/femoral tunnel angle in cadavers. With the inside-out technique, 120° of flexion produces smaller angles than does 90° of flexion. The outside-in technique results in lower angles and perhaps lower graft failure rates. However, additional clinical studies are needed.